Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB-ALIP: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

46.3%
Female
53.7%
Male

Age Information

The average age of patients reporting adverse events with NIRSEVIMAB-ALIP is 3.3 years.

Geographic Distribution

The majority of adverse event reports for NIRSEVIMAB-ALIP originate from US.

Report Summary & Outcomes

783
Total Reports
783
As Primary/Secondary Suspect
32
Deaths Reported
281
Hospitalizations
34
Life-Threatening
5
Disabilities

Reporting Timeline

First adverse event report: 20230101. Most recent report: 20250923. View full timeline →

More About NIRSEVIMAB-ALIP

NIRSEVIMAB-ALIP Full Profile Reports by Year Drug Interactions